Buyer GuideSeptember 17, 2026 · 18 min read · VEMERIX

Which Laser-Safety File Belongs With a 1470 nm Fiber Shipment

An incoming-inspection and supplier-qualification guide for international medical-device distributors, hospital clinical-engineering leads, and OEM buyers evaluating Chinese 1470 nm endovenous laser fiber shipments, partner-supplied generators, IEC 60601-2-22 editions, Laser Notice 56, and GB 9706.222 on 17 September 2026.

Laser SafetyIEC 60601Endovenous Laser FiberSupplier Qualification
Buyer-guide cover for incoming 1470 nm laser fiber safety file audit: fiber carton versus generator carton, FDA Rec 12-356, Rec 12-268 sunset, Laser Notice 56, and GB 9706.222

This guide is for regulatory-affairs managers, hospital clinical-engineering teams, quality auditors, and medical-device distributors auditing incoming shipments of sterile single-use 1470 nm endovenous laser ablation (EVLA) fibers. Trading companies and contract manufacturers often mix capital-console certifications with consumable sterilization files. On 17 September 2026, the incoming job is to split the generator carton from the sterile waveguide carton, read the exact standard-edition string, and send back a file that belongs to the other legal manufacturer.

Does an IEC 60601-2-22 CoA in a 1470 nm fiber carton prove Rec 12-356, or only that someone tested laser equipment?

When an incoming shipment of sterile single-use 1470 nm radial laser fibers arrives with a Certificate of Analysis (CoA) or test report citing IEC 60601-2-22, import specialists often treat that string as proof that the fiber carton has met international electrical and laser-safety criteria. The published scope of the US consensus recognition says otherwise.

Under FDA Recognized Consensus Standards Recognition Number 12-356, IEC 60601-2-22 Edition 4.0 2019-11 applies to medical electrical equipment that incorporates a Class 3B, Class 4, or Class 1C-with-enclosed-3B/4 laser as a source of energy transferred to the patient1. A typical sterile endovenous laser fiber is a passive optical waveguide—silica core, cladding, jacket, strain relief, and a connector such as SMA905—used with an external diode source. It contains no laser cavity and generates no photons. Connector geometry belongs in the 1470 nm radial fiber specification and compatibility file, not in the 2-22 particular.

Placing an IEC 60601-2-22 test report inside a carton of sterile laser fibers proves only that somewhere in the vendor's file set, an active laser console was tested to that particular. It does not validate sterility, biocompatibility, or optical transmission of the fibers in the box. Offering a generator particular in lieu of the fiber's consumable records is a carton-identity failure: send the pack back and ask for the fiber legal manufacturer's named instrument.

As established in our baseline analysis on which part is the device: laser fiber versus generator registers, agencies keep separate listings for laser consoles and surgical fibers. The console is active surgical equipment subject to electrical and laser-safety particulars. The fiber is evaluated as a sterile invasive consumable. Presenting the console particular in lieu of the fiber file leaves the shipment unverified on the questions that actually attach to the carton.

What did 24 April 2026 change when IEC published AMD1:2026, and why is that amendment not FDA Rec 12-356?

On 24 April 2026—146 days before 17 September 2026—IEC Technical Committee 76 published IEC 60601-2-22:2019/AMD1:20263. The public shop card lists a 6-page amendment; the normative difference table is paywalled and is not reproduced here. Commercial webstores listed the PDF for sale, and automated search summaries began treating AMD1:2026 as the current safety benchmark for all medical laser devices. That shop listing is not a US or China recognition.

Commercial availability of an IEC amendment is not national regulatory recognition. As of 17 September 2026, FDA Recognition Number 12-356 names IEC 60601-2-22 Edition 4.0 2019-11 (unamended) as Complete1. The SIS date of entry is 29 May 2024 (FR List 062), and the standard is included in FDA's ASCA program. FDA has not issued a recognition number for AMD1:2026. Consensus-standard declarations of conformity are a voluntary premarket route; Rec 12-356 does not require AMD1:2026.

FDA's Standards Information Search (SIS) still carries a transition statement for the preceding edition. Recognition Number 12-268 (IEC 60601-2-22 Edition 3.1 2012-10) entered on 14 January 2014 (FR List 033)2. Both SIS cards state that declarations of conformity to Rec 12-268 will be accepted in premarket submissions until 4 July 2027—290 days after this as-of date1, 2. A US English search snapshot captured on 17 September 2026 ranked that older Rec 12-268 page at organic position 6 for the query IEC 60601-2-22, ahead of Rec 12-356.

Consequently, an incoming audit conducted on 17 September 2026 must recognize three concurrent operational realities for the laser generator:

  1. Rec 12-356 is the current Complete recognition: Edition 4.0 2019-11 is named on the SIS card, without AMD1:2026.
  2. Rec 12-268 remains an accepted DoC until 4 July 2027: Edition 3.1 2012-10 is still a lawful premarket declaration during the printed transition. It is not proof that a fiber carton has the right file.
  3. IEC AMD1:2026 is a published international amendment, not Rec 12-356: Offering the shop PDF as if it were the FDA recognition is a send-back. Do not scrape the paywalled difference list.

The Laser-Safety Standard & Regulatory Identity Matrix

To eliminate market confusion between international IEC standards, US FDA consensus recognitions, CDRH radiation-safety overlays, and Chinese national standards, the matrix below details the exact legal status, scope, and applicability of each governing instrument as of 17 September 2026.

Instrument / Standard StringAuthority / Status as of 17 September 2026Scope & Equipment DefinitionAdoption & Relationship to IEC BaseDestination Market Overlay & Acceptability
FDA Rec 12-356 (IEC 60601-2-22 Edition 4.0 2019-11)US FDA CDRH / Complete recognition (Date of entry 29 May 2024, FR List 062)Medical electrical equipment incorporating Class 3B/4 or Class 1C laser transferring energy to patientsConsensus recognition of unamended IEC 60601-2-22:2019; does not include AMD1:2026US 510(k) Complete-recognition DoC route for laser equipment; Laser Notice 56 is listed as supportive guidance and still names Ed. 3.1
FDA Rec 12-268 (IEC 60601-2-22 Edition 3.1 2012-10)US FDA CDRH / transition still open; DoCs accepted until 4 July 2027 (290 days remaining)Diagnostic and therapeutic laser equipment; ME equipment incorporating laser sourcesConsensus recognition of IEC 60601-2-22:2007+A1:2012 (Edition 3.1)Acceptable in US premarket declarations of conformity until 4 July 2027; 17 Sep 2026 SERP ranked this SIS URL at position 6
IEC 60601-2-22:2019/AMD1:2026International Electrotechnical Commission / Published 24 April 2026 (146 days elapsed)Surgical, cosmetic, therapeutic, and diagnostic laser equipment incorporating laser sourcesAmendment 1 to Edition 4.0 (TC 76); 6-page shop card; normative difference table paywalledPublished international amendment; not named on Rec 12-356 or on the SAMR GB 9706.222 catalog card
FDA Laser Notice No. 56 (Guidance for Industry)US FDA CDRH / In force (Issued 8 May 2019, revised PDF issued 21 February 2023)Electronic radiation-emitting products subject to 21 CFR 1040.10 and 1040.11Guidance: FDA does not intend to enforce specified 21 CFR 1040.10/1040.11 clauses where comparable IEC 60825-1 Ed. 3 and 2-22 Ed. 3.1 clauses are metUS radiation-control overlay for laser products; 21 CFR 1010.2 certification remains a regulation. Notice 50 withdrawn 31 Dec 2024
FDA Rec 12-273 (IEC 60825-1 Edition 2.0 2007-03)US FDA CDRH / Complete recognition (Date of entry 9 July 2014, FR List 036)SIS title: equipment classification and requirements for laser products; example codes include GEXConsensus recognition of IEC 60825-1:2007 Edition 2.0; sole 60825 recognition in SISStill printed on FDA GEX product classification page; Laser Notice 56 permits Ed. 3 for CDRH reports
GB 9706.222-2022SAMR / SAC / Mandatory national standard, status 现行 (In Force since 1 May 2024)Medical electrical equipment — Particular requirements for laser equipmentModified adoption (修改采用) of IEC 60601-2-22:2019; completely replaces GB 9706.20-2000Mandatory for all medical laser generators registered or marketed in China; not a fiber standard
GB 9706.20-2000SAMR / SAC / Mandatory national standard, status 废止 (Abolished 1 May 2024); issued 18 December 2000Safety of diagnostic and therapeutic laser equipmentIdentical adoption (等同采用) of IEC 60601-2-22:1995Completely obsolete; CoAs citing GB 9706.20-2000 after 1 May 2024 indicate an invalid supplier file
Table 1: The Laser-Safety Standard & Regulatory Identity Matrix (Status as of 17 September 2026)

Source: US FDA Recognized Consensus Standards SIS (Rec 12-356, 12-268, 12-273), SAMR catalog cards for GB 9706.222-2022 and GB 9706.20-2000, IEC AMD1:2026 shop card, Laser Notice 56 guidance, and FDA radiation-emitting-product FAQ

Table 1 is an identity split, not a ranking of stringency. An IEC 60601-2-22:2019 report is not Chinese market authorization (which, for laser equipment, names GB 9706.222-2022). Laser Notice 56 is not a 510(k) consensus-standard DoC (that route is Rec 12-356 or Rec 12-268 until 4 July 2027). None of the seven rows is the fiber specification or sterility pack.

If a pouch copies a Laser Notice 56 statement from the console, which file is missing?

Incoming inspection of Asian-manufactured surgical fibers sometimes finds sterile-barrier pouches that copy radiation-certification wording from the generator. Auditors see Tyvek pouches printed with the Laser Notice 56 medical-device certification statement from FDA's guidance PDF: "Complies with 21 CFR 1040.10 and 1040.11 except for conformance with IEC 60825-1 Ed. 3 and IEC 60601-2-22 Ed. 3.1, as described in Laser Notice No. 56, dated May 8, 2019."5

When a sterile fiber pouch displays that statement, two files are usually missing: the console still needs its own 21 CFR 1010.2 certification on the laser product, and the fiber still needs its consumable dossier.

Under 21 CFR 1040.10(b)(21), a laser product is "any manufactured product or assemblage of components which constitutes, incorporates, or is intended to incorporate a laser or laser system"7. Apply that definition to the SKU in the carton. A sterile single-use optical waveguide that does not constitute, incorporate, or is not intended to incorporate a laser is not automatically inside it. The component exemption in 21 CFR 1040.10(a) is a different, narrower test that still assumes the article is a laser product; it is not the first question for a passive fiber7. This article does not issue a legal opinion that every fiber SKU is outside 21 CFR 1040.

Laser Notice No. 56 is CDRH guidance—originally issued 8 May 2019, current PDF issued 21 February 2023—describing FDA's intent not to enforce specified 21 CFR 1040.10 and 1040.11 requirements when manufacturers conform to comparable clauses of IEC 60825-1 Edition 3 and IEC 60601-2-22 Edition 3.14, 5, 6. Guidance is not a regulation. For laser products, 21 CFR 1010.2 still requires a certification label or tag. Laser Notice 56 offers alternative English certification wording FDA does not intend to enforce 21 CFR 1010.2 against, provided the comparable IEC clauses are met5. That label belongs on the laser product—typically the generator housing—not on a sterile fiber pouch.

When a contract sterilizer or factory copies this label onto a sterile fiber pouch, three distinct compliance failures occur:

  1. Wrong-object labeling: Copying a laser-product certification statement onto a fiber pouch invites the carton to be treated as an electronic radiation-emitting product. Form FDA 2877 is the import declaration for products that are actually subject to a radiation performance standard15; it is not a fiber-carton document. Ask why the statement is on the pouch, and whether the SKU meets 21 CFR 1040.10(b)(21).
  2. Missing console radiation file: Printing the statement on the fiber pouch does not satisfy 21 CFR 1010.2 for the generator, which must carry its own certification label on the equipment.
  3. Missing fiber consumable dossier: The vendor has substituted an irrelevant radiation-control statement for the fiber file: the fiber's own registration or 510(k) identity, named sterilization lot release, and ISO 10993 biocompatibility. Connector and optical checks belong in the specification pack, not in 21 CFR 1040.

Auditors must also check whether console inventory still cites Laser Notice No. 50. FDA's radiation-emitting-product FAQ, current as of 23 July 2026, records that FDA announced the transition on 7 June 2023 and that Laser Notice 50 was withdrawn on 31 December 202415. After that date, new certifications must use 21 CFR 1040.10/1040.11 or the Laser Notice 56 comparable-clause path. Products properly certified under Notice 50 on or before 31 December 2024 may still enter US commerce; they do not have to be recertified solely because Notice 50 was withdrawn15. A generator manufactured in 2025 that still prints Notice 50 on a new certification label is the send-back. The February 2023 Laser Notice 56 PDF still says it does not replace Notice 50; the later FAQ is the withdrawal authority5, 15. UL's industry note is a SERP competitor, not the FDA text12. For the fiber market-entry pack, see registering and distributing a single-use endovenous laser fiber.

Is GB 9706.222-2022 identical to IEC 60601-2-22 Edition 4.0, and why is a GB 9706.20-2000 CoA after 1 May 2024 a send-back?

In Chinese medical device procurement and registration, active electrical safety standards have undergone a massive, multi-year overhaul. Parallel to the general electrical safety transition examined in our guide on when a GB 9706.1 CoA is not IEC 60601-1 Edition 3.2, surgical laser equipment in China is governed by its own mandatory particular standard: GB 9706.222-2022.

Official SAMR catalog records establish that GB 9706.222-2022 was issued on 15 March 2022 and implemented on 1 May 202410. Status is 现行 (In Force). SAMR classifies the international relationship as 修改采用 (Modified Adoption) of IEC 60601-2-22:2019 (Edition 4.0)10. Modified adoption is not identical adoption (等同采用). The public catalog card does not print the national-deviation list, and this article does not reconstruct paywalled GB clauses. A Chinese generator file still needs its own general electrical-safety and collateral instruments; those overlays are the subject of when a GB 9706.1 CoA is not IEC 60601-1 Edition 3.2, not proof that GB 9706.222 already is Rec 12-356.

Simultaneously, SAMR's official platform records that the predecessor standard—GB 9706.20-2000 (which was an identical adoption of the obsolete IEC 60601-2-22:1995)—was officially abolished (废止) on 1 May 2024, completely replaced by GB 9706.222-202210, 11.

The implications for incoming supplier audits are stark:

  1. GB 9706.20-2000 is an immediate send-back after 1 May 2024: Any Chinese type-test report or factory CoA dated after 1 May 2024 that cites GB 9706.20-2000 cites an abolished standard.
  2. GB 9706.222-2022 does not equal US FDA Rec 12-356: Both derive from IEC 60601-2-22:2019, but a Chinese particular report is not a Rec 12-356 DoC. Do not treat a GB 9706.1 US-national-difference overlay (Rec 19-46) as the 2-22 gap analysis.
  3. GB 9706.222 belongs to the generator: It is a particular for laser equipment. It has no applicability to a sterile disposable optical fiber as a substitute fiber file.

Does the GEX classification page listing Rec 12-273 (IEC 60825-1 Edition 2.0) close the edition question for a 2026 fiber shipment?

Buyers researching US requirements for surgical lasers often open the FDA Product Classification Database for Product Code GEX (Powered laser surgical instrument, 21 CFR 878.4810, Class II, 510(k))8. The public GEX landing page lists Rec 12-273 (IEC 60825-1 Edition 2.0 2007-03) among recognized consensus standards and does not list Rec 12-3568, 9. IEC 60825-1 Edition 3.0 is also absent from that page.

A SIS search for referencenumber=60825 on 17 September 2026 returned only Rec 12-273, identification 32410, date of entry 9 July 2014, FR List 036, Complete9. That row's example product codes include GEX. Does the GEX landing page therefore close a 2026 fiber or console audit at Edition 2.0 of IEC 60825-1?

Absolutely not. This represents a classic public database synchronization gap that traps inexperienced auditors:

  • Product-code lists are examples, not an exhaustive edition roster: FDA notes that listed standards are examples and others may apply. Rec 12-356's SIS card lists LNK under 21 CFR 878.4810 and does not print GEX; the card also says examples are not exhaustive. Absence of Rec 12-356 on the GEX page is not proof that Edition 4.0 2-22 is unrecognized.
  • Laser Notice 56 is a radiation overlay, not a SIS Edition 3.0 row: SIS still has no numbered Rec for IEC 60825-1 Edition 3.0. Laser Notice 56 is guidance that names IEC 60825-1 Ed. 3 and IEC 60601-2-22 Ed. 3.1 as comparable clauses for specified 21 CFR 1040 requirements4, 5. That is not a Rec 12-356 DoC, and it is not a fiber-carton file.
  • Passive fibers still need their own specification pack: Under GEX, fiber 510(k)s evaluate optical interface, mechanical integrity, biocompatibility, and sterilization. Those questions are not answered by copying a 60825 class marking from the console. See 1470 nm radial fiber specifications and compatibility.

Do not rebuild the SMA905, core-diameter, numerical-aperture, or tip-geometry RFQ here. That file is already the specification-compatibility guide.

Fiber Carton versus Generator Carton: Complete File-Ownership Matrix

To ensure incoming inspection protocols correctly segregate documentation, Table 2 delineates the precise file-ownership boundaries between the sterile 1470 nm fiber carton and the active diode laser generator carton.

Regulatory / Quality InstrumentFiber Carton (Sterile 1470 nm Waveguide)Generator Carton (Diode Laser Console)Carton Mismatch Red Flag
IEC 60601-2-22 Particular Report / CoAExcluded. Fiber does not incorporate a laser source; 2-22 does not apply.Generator file. US premarket DoC route: Rec 12-356 (Edition 4.0) or Rec 12-268 (Edition 3.1) until 4 July 2027.Presenting an IEC 60601-2-22 CoA in the fiber carton indicates conflated product files.
Laser Notice 56 Statement (21 CFR 1040)Not automatic. Apply 21 CFR 1040.10(b)(21) to the SKU; a waveguide that does not incorporate a laser is not automatically a laser product.Laser-product file. 21 CFR 1010.2 certification on the console; Laser Notice 56 is the current comparable-clause overlay after Notice 50's withdrawal.Printing Laser Notice 56 wording on a sterile fiber pouch is the wrong object; apply 21 CFR 1040.10(b)(21) to the SKU.
IEC 60825-1 Laser Radiation ClassificationExcluded. Fiber has no standalone radiation emission classification.Generator file. Classify and label the console under 60825 / 21 CFR 1040; class depends on accessible emission, not a default Class 4 stamp.Marking a fiber pouch as 'Class 4' copies the console hazard class onto a consumable.
GB 9706.222-2022 Mandatory Test ReportExcluded. Chinese particular standard applies strictly to active laser equipment.Mandatory in China for laser equipment since 1 May 2024; replaces GB 9706.20-2000.Submitting GB 9706.222 for a fiber shipment or submitting abolished GB 9706.20-2000 for a console.
Premarket Clearance / RegistrationMandatory. Fiber's own Class II clearance/registration (e.g. NMPA Lu Mech Reg. 20192010517).Mandatory. Console's own Class III/II registration (e.g. NMPA Guo Xie Zhu Zhun 20253011190).Attempting to import fibers using the console manufacturer's premarket registration.
Sterilization Dossier (ISO 11135 / EO)Required when the labelled process is EO (or the named alternate method). Ask for the standard, cycle identity, residuals, and lot release.Excluded. Capital console is not delivered sterile and is never reprocessed with EO.Supplying an active console electrical report in place of an ISO 11135 sterilization certificate.
Biocompatibility File (ISO 10993)Required for patient-contacting fiber components. Ask for the ISO 10993 plan that matches contact duration and tissue; do not invent a fixed assay list.Excluded from patient contact. Only console exterior casing / user touchpoints evaluated.Missing blood-contact hemocompatibility data for intravascular fiber components.
Optical Transmission & Connector TolerancesRequired. Connector standard (often SMA905), core, NA, and transmission as specified for that SKU.Mandatory. SMA905 optical receptacle alignment, interlock switch, and power calibration.Mismatched optical connector tolerances causing energy leakage or cladding stripping.
Table 2: Fiber Carton versus Generator Carton File-Ownership Matrix

Source: Editorial file-ownership split compiled from FDA Rec 12-356 / 12-268 / 12-273 SIS, 21 CFR 1040.10, Laser Notice 56, SAMR GB 9706.222-2022 / GB 9706.20-2000, and the public VEMERIX fiber and NOVACURE product pages (September 2026)

When acquiring turnkey endovenous systems, procurement teams must also evaluate the total commercial configuration. As detailed in our breakdown of 1470 nm endovenous laser system price and total cost, bundling capital equipment quotes with disposable consumable contracts requires strict contractual separation of warranty, servicing, and sterilization liabilities.

Active Horizons and Transition Clocks Across Laser-Safety Standards

To assist regulatory teams in managing inventory transitions and avoiding expired standards in supplier files, Table 3 outlines the key historical and upcoming regulatory milestones across Chinese, US, and international jurisdictions.

Date MilestoneStandard / Instrument EventRegulatory AuthorityImpact on Generator CartonImpact on Fiber Carton
1 May 2024GB 9706.222-2022 implemented; GB 9706.20-2000 abolishedChina SAMR / NMPAMandatory implementation for all Chinese laser consoles; legacy 2000 standard abolished.Zero legal impact on fiber. Fiber continues under consumable registration.
29 May 2024FDA Rec 12-356 entered into consensus database (FR List 062)US FDA CDRHIEC 60601-2-22 Edition 4.0 recognized as Complete; established 4 July 2027 transition deadline.Zero impact. FDA premarket notification for fiber evaluates consumable GEX file.
31 December 2024Laser Notice 50 officially withdrawnUS FDA CDRHNew certifications after 31 Dec 2024 cannot use Notice 50; previously certified Notice 50 products may still enter commerce.No automatic 1040 duty for a waveguide that does not meet 21 CFR 1040.10(b)(21).
24 April 2026IEC 60601-2-22:2019/AMD1:2026 published (146 days ago)International Electrotechnical CommissionInternational publication available; not yet adopted into FDA Rec 12-356 or Chinese GB.Zero impact. Passive waveguide contains no active electronics or laser cavity.
17 September 2026Current live operational benchmark dateGlobal complianceRec 12-356 in force; Rec 12-268 accepted; Notice 56 required; GB 9706.222 in force.Consumable ISO 11135, ISO 10993, and SMA905 dimensional compliance required.
4 July 2027FDA Rec 12-268 transition expires (290 days remaining)US FDA CDRHFDA will cease accepting declarations of conformity to Edition 3.1; Edition 4.0 mandatory.Zero impact on fiber premarket clearance.
Table 3: Active Horizons and Transition Clocks Across Laser-Safety Standards

Source: US FDA SIS transition statements and radiation-emitting-product FAQ, SAMR catalog implementation/abolition dates, and IEC AMD1:2026 publication date

To visualize the lifespan of these regulatory instruments and the remaining transition windows, the chart below illustrates the duration and operational horizons across international and national laser safety benchmarks as of 17 September 2026.

Lifespans and Regulatory Clocks for Medical Laser-Safety Standards and FDA Consensus Recognitions (Months)
GB 9706.20-2000Issue-to-Abolition Span (Dec2000–May 2024)Months Elapsed / Regulatory Window: 280280FDA Rec 12-268 (Ed. 3.1) TotalRecognition Horizon to 2027SunsetMonths Elapsed / Regulatory Window: 161161FDA Rec 12-268 (Ed. 3.1) ActiveHorizon Pre-Sunset (Jan 2014–Sep2026)Months Elapsed / Regulatory Window: 152152IEC 60601-2-22 Edition 4.0Published Horizon (Nov 2019–Sep2026)Months Elapsed / Regulatory Window: 8282GB 9706.222-2022 MandatoryIn-Force Duration (Since May2024)Months Elapsed / Regulatory Window: 2828FDA Rec 12-356 (Ed. 4.0Complete) Recognition Horizon(Since May 2024)Months Elapsed / Regulatory Window: 2727Remaining Transition Window: Rec12-268 DoC Acceptance (To July2027)Months Elapsed / Regulatory Window: 99IEC 60601-2-22 AMD1:2026Published Horizon (Since April2026)Months Elapsed / Regulatory Window: 55
View chart data
CategoryMonths Elapsed / Regulatory Window
GB 9706.20-2000 Issue-to-Abolition Span (Dec 2000–May 2024)280
FDA Rec 12-268 (Ed. 3.1) Total Recognition Horizon to 2027 Sunset161
FDA Rec 12-268 (Ed. 3.1) Active Horizon Pre-Sunset (Jan 2014–Sep 2026)152
IEC 60601-2-22 Edition 4.0 Published Horizon (Nov 2019–Sep 2026)82
GB 9706.222-2022 Mandatory In-Force Duration (Since May 2024)28
FDA Rec 12-356 (Ed. 4.0 Complete) Recognition Horizon (Since May 2024)27
Remaining Transition Window: Rec 12-268 DoC Acceptance (To July 2027)9
IEC 60601-2-22 AMD1:2026 Published Horizon (Since April 2026)5

Operational clocks as of 17 September 2026, in whole months using days/30.44 from the named start and end dates. Bars mix different clocks (abolished-GB lifespan, remaining DoC window, published-amendment age) and are not a ranking of technical stringency. Compiled from SAMR catalog dates, IEC publication dates, and FDA SIS.

Source: State Administration for Market Regulation (SAMR), International Electrotechnical Commission (IEC), and US FDA Recognized Consensus Standards database (September 2026)

Red-flag checklist: Five incoming laser-safety file failure modes that require immediate send-back

When receiving technical files and CoAs for incoming 1470 nm laser fiber shipments, auditors should screen for five recurring failure modes that justify immediate rejection of the documentation packet:

  1. Red Flag 1: IEC 60601-2-22 CoA inside the fiber carton, or a 'Class 4 fiber' stamp. The report evaluates laser equipment, not the sterile waveguide. Action: Send back. Request the fiber legal manufacturer's identity, named sterilization lot release, biocompatibility, and optical/connector file. Require the vendor to remove generator hazard class from consumable packaging.
  2. Red Flag 2: A 2025+ certification label that still cites withdrawn Laser Notice 50. FDA withdrew Notice 50 on 31 December 2024; new certifications after that date must use 21 CFR 1040 or Laser Notice 56. Previously certified Notice 50 product reports may still enter commerce. Action: Reject a newly manufactured 2025 console that still prints Notice 50. Do not treat companion fibers as illegal solely because the console label is stale.
  3. Red Flag 3: GB 9706.20-2000 after 1 May 2024. That GB was abolished when GB 9706.222-2022 was implemented. Action: Reject the dossier for a Chinese generator claim.
  4. Red Flag 4: AMD1:2026 shop PDF offered as Rec 12-356. Rec 12-356 names unamended Edition 4.0 2019-11. Rec 12-268 DoCs remain acceptable through 4 July 2027. Action: Correct the supplier; do not scrape the paywalled amendment.
  5. Red Flag 5: A bare 'complies with IEC 60601-2-22' statement with no edition and no accredited report. Action: Require the named edition (3.1 versus 4.0 versus AMD1) and the test-report identity for the generator legal manufacturer—not a one-line CoA in the fiber carton.

Understanding these documentary traps is vital to clinical safety. As reviewed in our investigation into what FDA MAUDE and recalls show about endovenous laser fiber failures, physical fiber failures during endovenous procedures—such as tip detachment, optical degradation, and vein perforation—stem from manufacturing defects, poor tip fusion, and material degradation, which are prevented by rigorous consumable qualification rather than console electrical reports.

Worked files: Four illustrative 1470 nm laser-safety incoming audits

The four files below are editorial worked examples, not VEMERIX customer cases and not claimed certificates. Public product pages do not publish a Rec 12-356, Laser Notice 56, or GB 9706.222 report for either SKU13, 14.

  • Worked File A: Sterile 1470 nm fiber carton packed with an IEC 60601-2-22 type-test summary.
    Hypothesis: A distributor importing sterile 1470 nm radial fibers receives an IEC 60601-2-22:2019 report that evaluates electrical insulation, protective earthing, and laser interlocks.
    Finding: Carton mismatch. The report is a generator particular.
    Write-back: Halt release. Request the fiber legal manufacturer's consumable dossier. For a Medison-labelled carton, that starts with NMPA Class II identity (Lu Mech Reg. 20192010517)13, then the named sterilization lot release and biocompatibility—not a 2-22 CoA.
  • Worked File B: 1470 nm console manufactured in March 2025 with a Laser Notice 50 certification label.
    Hypothesis: A US buyer receives a turnkey suite. The console rating plate prints Notice 50 (24 June 2007).
    Finding: New 2025 certification cannot use withdrawn Notice 5015. Companion fibers are not automatically illegal.
    Write-back: Require an updated Laser Notice 56 (or 21 CFR 1040) certification path for that console serial, and keep the fiber carton on its own file.
  • Worked File C: Chinese hospital tender pack citing GB 9706.20-2000 after abolition.
    Hypothesis: A provincial tender packet includes a type-test citing GB 9706.20-2000.
    Finding: Abolished standard. GB 9706.20-2000 was abolished 1 May 202411.
    Write-back: Require GB 9706.222-2022 for the generator. Do not treat that report as the fiber carton file.
  • Worked File D: OEM told that AMD1:2026 testing is required before a US 510(k) DoC.
    Hypothesis: A factory claims the console cannot be filed until it is tested to AMD1:2026.
    Finding: Rec 12-356 names unamended Edition 4.0 2019-11; Rec 12-268 DoCs remain acceptable until 4 July 20271, 2, 3.
    Write-back: Name the SIS recognition actually used. Do not buy the amendment PDF as if it were Rec 12-356.

Where VEMERIX fits—and where due diligence still begins

In the international vascular surgery and minimally invasive consumables sector, VEMERIX (the international brand of Weihai Medison Medical Equipment Co., Ltd.) maintains strict transparency regarding product classification, manufacturing truth, and regulatory boundaries.

The core consumable of the VEMERIX 1470 nm endovenous laser platform is Medison's Disposable Medical Laser Fiber. Public product documentation records an NMPA Class II device (Lu Mech Reg. 20192010517), single-use and sterile, designed for 1470 nm endovenous workflows and paired with a partner-supplied diode laser source13. That page does not name IEC 60601-2-22, Laser Notice 56, Rec 12-356, GB 9706.222, ISO 11135, or SMA905. Buyers should still request the named sterilization method, lot release, biocompatibility, and connector/optical file for the carton in front of them. This article does not claim that VEMERIX already holds those laser-safety certificates, or that a published lot-specific CoA pack is on the product page.

When partners want a turnkey platform, VEMERIX pairs the fiber with the NOVACURE Semiconductor Laser Treatment System. Product truth: NOVACURE is an NMPA Class III device (Guo Xie Zhu Zhun 20253011190) held by Guangdong Yunshang (white-label production)14. VEMERIX does not manufacture, own, or register that console. Electrical-safety, laser-particular, GB 9706.222, and Laser Notice 56 filings for NOVACURE remain that legal manufacturer's file. This article does not claim those certificates.

For international distributors and OEM partners, due diligence begins by inspecting each carton independently:

  • For the fiber carton: Verify Medison's Class II identity (Lu Mech Reg. 20192010517), then request the named sterilization lot release, biocompatibility, and optical/connector evidence. Do not demand an IEC 60601-2-22 report for this carton.
  • For the generator carton: If sourcing partner-supplied NOVACURE, verify Guangdong Yunshang's Class III registration and ask for the named 2-22 edition, radiation-certification path, and—if China electrical-safety of the console is claimed—GB 9706.222.
  • For custom OEM agreements: Review quality agreements via our quality assurance overview or contact. Due diligence still begins with the named instrument on each carton.

Distributor RFQ checklist: Laser-safety incoming audit gates

When issuing a Request for Quotation (RFQ) or conducting incoming supplier audits for 1470 nm laser systems, distributors should enforce the five structured audit gates detailed in Table 4.

Audit GateDocument Required from SupplierEdition / Clause Identity CheckSend-Back Trigger
Gate 1: Carton Identity & Legal ManufacturerManufacturer registration certificate and commercial invoice per cartonConfirm fiber carton identifies fiber legal manufacturer; console carton identifies console manufacturerFiber carton identifying console manufacturer or omitting consumable registration
Gate 2: Generator IEC 60601-2-22 Particular EditionFull CB Scheme Test Certificate and test report for laser consoleName Rec 12-356 (Edition 4.0 2019-11) or Rec 12-268 (Edition 3.1 until 4 July 2027); AMD1:2026 is not Rec 12-356IEC 60601-2-22 CoA inside fiber carton, or unaccredited 'conformance statement'
Gate 3: US Radiation Control & Laser Notice OverlayCDRH Accession Number letter and console chassis certification label photoIf the SKU is a laser product: 21 CFR 1040.10/1040.11 or Laser Notice 56 comparable clauses (Ed. 3 / Ed. 3.1); Notice 50 withdrawn 31 Dec 2024Console manufactured in 2025+ citing Laser Notice 50, or Laser Notice 56 printed on fiber pouch
Gate 4: China GB 9706.222 In-Force Particular StatusNMPA accredited testing institute type-test report for Chinese marketVerify GB 9706.222-2022 (implemented 1 May 2024, MOD IEC 60601-2-22:2019)Test report citing abolished GB 9706.20-2000 or claiming GB 9706.222 applies to fiber
Gate 5: Fiber Consumable Direct Quality PackFiber Device Master Record extract: named sterilization lot release, biocompatibility, optical/connectorNamed process (often ISO 11135 when EO is labelled), ISO 10993-7 residuals where EO applies, ISO 10993 contact set, connector dimensionsVendor substituting console electrical reports for the fiber's own sterilization and biocompatibility records
Table 4: Distributor RFQ Checklist: Laser-Safety Incoming Audit Gates

Source: Editorial incoming-audit gates compiled from the cited FDA SIS, Laser Notice 56, 21 CFR 1040.10, SAMR catalog, and public product-identity pages (September 2026)

Frequently asked questions

Is IEC 60601-2-22:2019/AMD1:2026 the same as FDA Rec 12-356?
No. AMD1:2026 is an IEC amendment published 24 April 2026. Rec 12-356 names unamended IEC 60601-2-22 Edition 4.0 2019-11 as Complete (entered 29 May 2024). FDA has not recognized AMD1:2026. A 510(k) DoC does not require AMD1:2026.

Can a US 510(k) for a disposable laser fiber accept a generator's IEC 60601-2-22 report in place of the fiber file?
No. A disposable surgical laser fiber 510(k) under product code GEX (21 CFR 878.4810) is a consumable file: optical interface, mechanical integrity, biocompatibility, and sterilization. IEC 60601-2-22 evaluates laser equipment that incorporates a laser source.

What happens on 4 July 2027 for IEC 60601-2-22 Edition 3.1 declarations of conformity?
That is the printed sunset for Rec 12-268. Until 4 July 2027 (290 days after 17 September 2026), FDA will accept DoCs to Edition 3.1 in premarket submissions. After that date, new DoCs must cite Rec 12-356 (Edition 4.0). The sunset does not convert a fiber carton into laser equipment.

If a 2025-dated laser console still cites Laser Notice 50, is the paired fiber shipment illegal?
Not automatically. FDA withdrew Notice 50 on 31 December 2024 for new certifications. Products properly certified under Notice 50 on or before that date may still enter commerce. A 2025 console that newly certifies to Notice 50 is non-compliant; keep the fiber carton on its own identity and sterility file.

Does GB 9706.222-2022 prove IEC 60601-2-22 Edition 4.0 or AMD1:2026?
It proves China's mandatory particular for laser equipment, recorded as modified adoption of IEC 60601-2-22:2019. It is not identical adoption, not AMD1:2026, and not Rec 12-356.

Is a sterile 1470 nm fiber a laser product under 21 CFR 1040.10(b)(21)?
Apply the definition to the SKU. A laser product constitutes, incorporates, or is intended to incorporate a laser or laser system. A passive waveguide that does not do those things is not automatically inside the definition. The 1040.10(a) component exemption is a different test. Do not treat a copied Laser Notice 56 pouch statement as proof either way.

Does an SMA905 connector specification or a GEX product code prove the laser-safety edition?
No. SMA905 is a connector geometry. GEX is a product-code heading. Neither names Rec 12-356, Rec 12-268, AMD1:2026, Laser Notice 56, or GB 9706.222.

Does VEMERIX claim a Rec 12-356, Laser Notice 56, or GB 9706.222 certificate in this article?
No. VEMERIX manufactures Medison's NMPA Class II single-use medical laser fiber (Lu Mech Reg. 20192010517). NOVACURE is an NMPA Class III partner-supplied console (Guo Xie Zhu Zhun 20253011190) held by Guangdong Yunshang. Console laser-safety certificates are that manufacturer's file.

Sources

  1. US Food and Drug Administration, Recognized Consensus Standards: Medical Devices, Recognition Number 12-356, Identification Number 45390. IEC 60601-2-22 Edition 4.0 2019-11, Medical electrical equipment — Part 2-22: Particular requirements for basic safety and essential performance of surgical, cosmetic, therapeutic and diagnostic laser equipment. Extent of recognition Complete. Date of entry 29 May 2024. FR Recognition List Number 062. Included in ASCA. Scope is laser equipment that incorporates a Class 3B, Class 4, or Class 1C-with-enclosed-3B/4 laser as a source of energy transferred to the patient. Note 1 directs Class 1/1M/2/2M/3R products to IEC 60825-1:2014 and the general standard. Transition: Rec 12-268 accepted until 4 July 2027. Supportive publications include Laser Notice 56.
  2. US Food and Drug Administration, Recognized Consensus Standards: Medical Devices, Recognition Number 12-268, Identification Number 45391. IEC 60601-2-22 Edition 3.1 2012-10, Medical electrical equipment — Part 2-22: Particular requirements for basic safety and essential performance of surgical, cosmetic, therapeutic and diagnostic laser equipment. Extent of recognition Complete. Date of entry 14 January 2014. FR Recognition List Number 033. FDA transition statement establishes that declarations of conformity to Rec 12-268 will be accepted until 4 July 2027.
  3. International Electrotechnical Commission, IEC 60601-2-22:2019/AMD1:2026, Amendment 1 — Medical electrical equipment — Part 2-22: Particular requirements for basic safety and essential performance of surgical, cosmetic, therapeutic and diagnostic laser equipment. Publication date 24 April 2026. Edition 4.0 amendment. Technical Committee 76 (Optical radiation safety and laser equipment). 6 pages. ISBN 9782832712160.
  4. US Food and Drug Administration, Laser Products — Conformance with IEC 60825-1 Ed. 3 and IEC 60601-2-22 Ed. 3.1 (Laser Notice No. 56), Guidance for Industry and FDA Staff. Document issued 21 February 2023; originally issued 8 May 2019. Docket FDA-2017-D-7011. Describes FDA's intent not to enforce specified 21 CFR 1040.10 and 1040.11 radiation-control requirements where comparable IEC clauses are satisfied.
  5. US Food and Drug Administration, Laser Notice No. 56 Guidance Document (PDF Version), Conformance with IEC 60825-1 Ed. 3 and IEC 60601-2-22 Ed. 3.1, issued 21 February 2023. Contains the table of comparable clauses and required certification-label statements under 21 CFR 1010.2.
  6. Federal Register, Laser Products — Conformance With IEC 60825-1 Ed. 3 and IEC 60601-2-22 Ed. 3.1 (Laser Notice No. 56); Guidance for Industry and FDA Staff; Availability, 84 FR 20140, 8 May 2019, Docket FDA-2017-D-7011.
  7. US Electronic Code of Federal Regulations (eCFR), Title 21, Chapter I, Subchapter J, Part 1040, Section 1040.10: Laser products. Sets forth applicability, component exemptions under paragraph (a), and definition of laser product under paragraph (b)(21) as any manufactured product or assemblage of components which constitutes, incorporates, or is intended to incorporate a laser or laser system.
  8. US Food and Drug Administration, Product Classification Database, Product Code GEX — Powered laser surgical instrument, 21 CFR 878.4810, Class II medical device, 510(k) premarket notification required. Recognized consensus standards listed on the classification record include Rec 12-273 and omit Rec 12-356.
  9. US Food and Drug Administration, Recognized Consensus Standards: Medical Devices, Recognition Number 12-273, Identification Number 32410. IEC 60825-1 Edition 2.0 2007-03, Safety of laser products — Part 1: Equipment classification and requirements, including Technical Corrigendum 1 (2008) and Interpretation Sheets 1 and 2 (2007). Extent of recognition Complete. Date of entry 9 July 2014. FR Recognition List Number 036. Example product codes on the SIS card include GEX under 21 CFR 878.4810. A SIS search for referencenumber=60825 on 17 September 2026 returned this as the sole 60825-1 row.
  10. State Administration for Market Regulation (SAMR), National Public Service Platform for Standards Information, catalog record for GB 9706.222-2022, Medical electrical equipment — Part 2-22: Particular requirements for basic safety and essential performance of surgical, cosmetic, therapeutic and diagnostic laser equipment. Mandatory national standard, status 现行 (In Force), issued 15 March 2022, implemented 1 May 2024. Completely replaces GB 9706.20-2000. 修改采用 (Modified Adoption) of IEC 60601-2-22:2019. Competent authority NMPA.
  11. State Administration for Market Regulation (SAMR), National Public Service Platform for Standards Information, catalog record for GB 9706.20-2000, Medical electrical equipment — Part 2: Particular requirements for the safety of diagnostic and therapeutic laser equipment. Mandatory national standard, status 废止 (Abolished), issued 18 December 2000, implemented 1 May 2001, abolished 1 May 2024. 等同采用 (Identical Adoption) of IEC 60601-2-22:1995. Completely replaced by GB 9706.222-2022.
  12. UL Solutions, Technical Insight: FDA Laser Notice 50 Withdrawal for Laser Certifications. Industry reading of the 7 June 2023 FDA bulletin and the 2025 manufacture-date cutoff. Used as a SERP-baseline competitor page; the withdrawal fact is taken from FDA's radiation-emitting-product FAQ, not from this commercial insight.
  13. Public VEMERIX Disposable Medical Laser Fiber product page. NMPA Class II medical device, registration Lu Mech Reg. 20192010517, single-use, sterile, individually packed, designed for 1470 nm endovenous laser workflows, pairing with a partner-supplied diode laser source. The page does not name IEC 60601-2-22, Laser Notice 56, Rec 12-356, GB 9706.222, ISO 11135, SMA905, or a published sterilization-cycle edition.
  14. Public VEMERIX NOVACURE Semiconductor Laser Treatment System product page. Partner-supplied diode laser console; NMPA Class III, Guo Xie Zhu Zhun 20253011190; registration holder Guangdong Yunshang (white-label production). Used with Medison single-use medical laser fibers. The page does not name a Rec 12-356, Laser Notice 56, or GB 9706.222 certificate held by VEMERIX.
  15. US Food and Drug Administration, Getting a Radiation Emitting Product to Market: Frequently Asked Questions. Q29 records that FDA announced on 7 June 2023 a transition from Laser Notice 50 to Laser Notice 56, and that Laser Notice 50 was withdrawn on 31 December 2024. Q31–Q32 state that laser products properly certified using Laser Notice 50 on or before 31 December 2024 may still enter US commerce, and that after that date new certifications must use 21 CFR 1040.10/1040.11 or the Laser Notice 56 comparable-clause path. Content current as of 23 July 2026. Q39 describes Form FDA 2877 for imported products that are subject to a radiation performance standard.

Talk to VEMERIX

VEMERIX is the international brand of Weihai Medison Medical Equipment Co., Ltd., positioned as a Minimally Invasive Surgery Total Solution Platform serving urology, vascular surgery and perioperative care.